NCT06802952 RTMS for CHR Based on Personalized Targets Using Magnetoencephalography
| NCT ID | NCT06802952 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Shanghai Mental Health Center |
| Condition | Clinical High-risk Syndrome of Psychosis |
| Study Type | INTERVENTIONAL |
| Enrollment | 26 participants |
| Start Date | 2025-02-07 |
| Primary Completion | 2026-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 26 participants in total. It began in 2025-02-07 with a primary completion date of 2026-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study is an before-after study in the same subject, which enrolled 26 individuals with high-risk psychiatric syndrome (CHR). The target of subjects intervention relies on the results of magnetoencephalography localization. The medication and dosage remain unchanged during the intervention period or not yet taking antipsychotic medication. The investigators assume that the intervention targets for each CHR subject are individualized.
Eligibility Criteria
Inclusion Criteria: * Clinical diagnosis of Clinical High-Risk Syndrome for Psychosis * Must be able to right-handed * Primary school education or above * Understand and sign a written informed consent form (jointly signed by the guardian and the participant if under 18 years old) Exclusion Criteria: * Major physical illnesses (organic lesions such as sensory and motor disorders, neurological disorders, and traumatic brain injury) * Taboo symptoms for rTMS treatment (such as intracranial metal implants) * Metal (including orthodontic treatment, dental implants) and tattoos inside the body * Claustrophobia
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06802952 clinical trial?
This trial is open to participants of all sexes, aged 13 Years or older, up to 35 Years, studying Clinical High-risk Syndrome of Psychosis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06802952 currently recruiting?
Yes, NCT06802952 is actively recruiting participants. Contact the research team at yeganghu@126.com for enrollment information.
Where is the NCT06802952 trial being conducted?
This trial is being conducted at Shanghai, China.
Who is sponsoring the NCT06802952 clinical trial?
NCT06802952 is sponsored by Shanghai Mental Health Center. The trial plans to enroll 26 participants.